Equity research analysts covering Astec LifeSciences and Astec Industries periodically adjust their consensus target prices based on quarterly financial performance, margin expansions, and broader market conditions. Because price targets change dynamically as new earnings reports and macroeconomic updates are published, investors typically look to live financial terminals or brokerage consensus summaries to find the most up-to-date twelve-month price projection for either security.